Infectious disease trials are fast paced and complex. Whether it’s finding the right subject populations worldwide, anticipating our customers' needs or understanding site challenges, Kendle has the experience to manage all the variables. In addition to Phase I-IV trials, we also excel in post-marketing pharmacovigilance, including expanded access and patient registry trials. Our detailed understanding of these programs enables us to plan, launch and execute them with great efficiency, precision and flexibility.
Kendle has conducted more than 280 infectious disease trials with various customers in the last five years, covering a wide range of indications. Our expert staff has an in-depth understanding of infectious disease as well as a strong foundation in the science underlying drug discovery and development. Their unparalleled experience has enabled us to build a strong database of investigators and sites invested in infectious diseases trials worldwide. We take pride in our therapeutic specialists and broad, international experience.